This volume focuses on new approaches in the molecular and clinical management of gastrointestinal tumours. The first part presents recent insights into carcinogenesis, including alterations in cycline and adhesion receptors, molecular structures which might be new targets of gene therapy. The second part offers new diagnostic tools, such as receptors for gastrointestinal hormones, proliferation markers, tumour suppressor proteins, and the multiple drug resistance gene, predicting response to therapy and prognosis of ...
Read More
This volume focuses on new approaches in the molecular and clinical management of gastrointestinal tumours. The first part presents recent insights into carcinogenesis, including alterations in cycline and adhesion receptors, molecular structures which might be new targets of gene therapy. The second part offers new diagnostic tools, such as receptors for gastrointestinal hormones, proliferation markers, tumour suppressor proteins, and the multiple drug resistance gene, predicting response to therapy and prognosis of gastrointestinal tumours. The third part gives an update of successful approaches in primary and secondary prevention of colorectal carcinoma.
Read Less
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Kreuser, Ernst D. Hardcover Edition in Very Good condition. Former owner's name is written in pen on the front cover and there is a small, light indentation near the center of the front cover; otherwise, the covers are in great shape. Rubbed edges and corners. The binding is square and tight. The interior pages are clean and unmarked. Small abrasion to the front flyleaf. The book will be carefully packaged for shipment for protection from the elements. USPS electronic tracking number issued free of charge. This volume focuses on new and exciting approaches in the molecular and clinical management of gastrointestinal tumors. The first part presents recent insights into carcinogenesis, including alterations in cyclins and adhesion receptors, molecular structures which might be new targets of gene therapy. The second part of the volume offers new diagnostic tools, such as receptors for gastrointestinal hormones, proliferation markers, tumor suppressor proteins, and the multiple drug resistance gene, predicting response to therapy and prognosis in gastrointestinal tumors. The third part gives an update of successful approaches in primary and secondary prevention of colorectal carcinoma. Nutritional factors and pharmacologic agents can clearly decrease the risk, and fecal occult blood tests and endoscopy can reduce the mortality in colorectal carcinoma. Laparoscopic staging with subsequent biopsy of suspicious lymph nodes provides essential information in esophageal and gastric cancer. In locally advanced gastric cancer, preoperative chemotherapy provides sufficient evidence to investigate this approach as compared to primary surgery. Standards have recently been established in the adjuvant treatment of patients with gastrointestinal carcinoma, and promising new drugs, including monoclonal antibodies, thymidylate synthase, and topoisomerase inhibitors, as well as taxoids, are currently being tested in phase I, II, and III trials of gastrointestinal tumors. 439 pages.